Tumor Biology

, Volume 37, Issue 12, pp 16187–16197 | Cite as

LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway

  • Dong Xue
  • Cuixing Zhou
  • Hao Lu
  • Renfang Xu
  • Xianlin Xu
  • Xiaozhou He
Original Article

Abstract

In prior research, evidence has been found for a relation between low exposure of long non-coding RNAs (lncRNAs) and prostate tumor genesis. This study aims to clarify the underlying mechanisms of lncRNA GAS5 in prostate cancer (PCa). In total, 118 pairs of PCa tissues and matched adjacent non-tumor tissues were collected. Additionally, lncRNA GAS5 exposure levels were determined using RT-PCR and in situ hybridization. In addition, dual-luciferase report assay was performed to verify the target effect of lncRNA GAS5 on miR-103. The exposure levels of the proteins related to the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) axis, including AKT, mTOR, and S6K1, were measured by western blot PC3 cells infected with lncRNA GAS5 mimic; lncRNA GAS5 siRNA; or a combination of lncRNA and miR-103. The proliferation, invasion, and migration ability of PC3 cells after being infected were tested by MTT assay, wound healing assay, and transwell assays. Finally, nude mouse xenograft models were used to measure lncRNA GAS5 effects on prostate tumor growth in vivo. The lncRNA GAS5 levels were reduced significantly in the PCa tissues and cell lines (P < 0.05). A low exposure of lncRNA GAS5 caused AKT/mTOR signaling pathway activation in PC3 cells (P < 0.05). In addition, over-exposure of lncRNA GAS5 was proven to significantly decelerate PCa cell progression in vitro and tumor growth in vivo through inactivating the AKT/mTOR signaling pathway (P < 0.05). This study proves that lncRNA GAS5 plays a significant role in the decelerating PCa development via mediating the AKT/mTOR signaling pathway through targeting miR-103.

Keywords

Prostate cancer LncRNA GAS5 miR-103 AKT/mTOR signaling pathway Proliferation Invasion Migration Xenograft model 

Notes

Acknowledgments

This work was supported by Changzhou Municipal Science and Technology Bureau Support Project (CE20135046) and Jiangsu Provincial Health Department General Research Project (H201348).

Compliance with ethical standards

The Animal Ethics Committee of Fudan University approved all protocols of animal experiments.

Conflicts of interest

None

References

  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRefPubMedGoogle Scholar
  2. 2.
    DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.CrossRefPubMedGoogle Scholar
  3. 3.
    Jilg CA, Ketscher A, Metzger E, et al. PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells. Oncotarget. 2014;5:12646–64.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578–83.CrossRefPubMedGoogle Scholar
  5. 5.
    Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–66.CrossRefPubMedGoogle Scholar
  6. 6.
    Yuan J, Yue H, Zhang M, et al. Transcriptional profiling analysis and functional prediction of long noncoding RNAs in cancer. Oncotarget. 2016;7:8131–42.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Smith CM, Steitz JA. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol. 1998;18:6897–909.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54:787–93.CrossRefPubMedGoogle Scholar
  9. 9.
    Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA gas5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Cao S, Liu W, Li F, et al. Decreased expression of lncRNA gas5 predicts a poor prognosis in cervical cancer. International journal of clinical and experimental pathology. 2014;7:6776–83.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. Gas5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28:195–208.CrossRefPubMedGoogle Scholar
  12. 12.
    Pickard MR, Mourtada-Maarabouni M, Williams GT. Long non-coding RNA gas5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta. 2013;1832:1613–23.CrossRefPubMedGoogle Scholar
  13. 13.
    Pickard MR, Williams GT. Molecular and cellular mechanisms of action of tumour suppressor gas5 lncRNA. Genes. 2015;6:484–99.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Zhao X, Wang P, Liu J, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Molecular therapy : the journal of the American Society of Gene Therapy. 2015;23:1899–911.CrossRefGoogle Scholar
  15. 15.
    Zhang Z, Zhu Z, Watabe K, et al. Negative regulation of lncRNA gas5 by miR-21. Cell Death Differ. 2013;20:1558–68.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell. 2005;8:179–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Yacqub-Usman K, Pickard MR, Williams GT. Reciprocal regulation of gas5 lncRNA levels and mTOR inhibitor action in prostate cancer cells. Prostate. 2015;75:693–705.CrossRefPubMedGoogle Scholar
  18. 18.
    Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–14.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Martello G, Rosato A, Ferrari F, et al. A microRNA targeting dicer for metastasis control. Cell. 2010;141:1195–207.CrossRefPubMedGoogle Scholar
  20. 20.
    Nonaka R, Miyake Y, Hata T, et al. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Int J Oncol. 2015;47:1097–102.PubMedGoogle Scholar
  21. 21.
    Yu D, Zhou H, Xun Q, et al. MicroRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol Lett. 2012;3:1221–6.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Li M, Liu Z, Zhang Z, et al. Mir-103 promotes 3t3-l1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D. Biol Chem. 2015;396:235–44.CrossRefPubMedGoogle Scholar
  23. 23.
    Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703–19.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Luo G, Wang M, Wu X, et al. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2015;37:2209–20.CrossRefGoogle Scholar
  25. 25.
    Prensner JR, Chen W, Han S, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16:900–8.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Liu Y, Zhao J, Zhang W, et al. LncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Scientific reports. 2015;5:10159.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Chang L, Li C, Lan T, et al. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin. Mol Med Rep. 2016;13:1541–50.PubMedGoogle Scholar
  28. 28.
    Liu Z, Wang W, Jiang J, et al. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS One. 2013;8:e73991.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Shain SA. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2. Molecular cancer research : MCR. 2004;2:653–61.PubMedGoogle Scholar
  30. 30.
    Romanuik TL, Wang G, Morozova O, et al. LNCaP atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med Genet. 2010;3:43.Google Scholar
  31. 31.
    Yu F, Zheng J, Mao Y, et al. Long non-coding RNA growth arrest-specific transcript 5 (GAS5) inhibits liver fibrogenesis through a mechanism of competing endogenous RNA. J Biol Chem. 2015;290:28286–98.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Pei J, Wang B. Notch-1 promotes breast cancer cells proliferation by regulating lncRNA GAS5. Int J Clin Exp Med. 2015;8:14464–71.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Xia W, Ni J, Zhuang J, et al. Mir-103 regulates hepatocellular carcinoma growth by targeting AKAP12. Int J Biochem Cell Biol. 2016;71:1–11.CrossRefPubMedGoogle Scholar
  34. 34.
    Barrett D, Brown VI, Grupp SA, et al. Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies. Paediatric drugs. 2012;14:299–316.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926–45.CrossRefPubMedGoogle Scholar
  36. 36.
    Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307–18.CrossRefPubMedGoogle Scholar
  37. 37.
    Pickard MR, Williams GT. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy. Breast Cancer Res Treat. 2014;145:359–70.CrossRefPubMedGoogle Scholar
  38. 38.
    Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11–22.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Song W, Wang K, Zhang RJ, et al. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis. Minerva Med. 2016;107:70–6.PubMedGoogle Scholar
  40. 40.
    Qiao HP, Gao WS, Huo JX, et al. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2013;14:1077–82.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Dong Xue
    • 1
  • Cuixing Zhou
    • 1
  • Hao Lu
    • 1
  • Renfang Xu
    • 1
  • Xianlin Xu
    • 1
  • Xiaozhou He
    • 1
  1. 1.Department of UrologyThird Affiliated Hospital, Suzhou UniversityChangzhouChina

Personalised recommendations